[1] 张晓玲,霍丽静,刘鹏,等.秦皇岛市替加环素对耐碳青酶烯类肺炎克雷伯菌体外抗菌活性研究[J].河北医药,2015,37(5):767-769. [2] 杨青,杜小苹,俞云松,等.5种药敏方法检测产KPC酶肠杆菌科细菌对碳青霉烯类抗生素的耐药性[J].浙江检验医学,2008,6(4):3-6. [3] 林佩贤,黄宝添,许斐斐,等.重症监护室多重耐药菌医院感染临床特点与耐药性分析[J].国际流行病学传染病学杂志,2015,42(4):228-231. [4] National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobialsusceptibility testing: M100-S17[S]. Pennsylvania: CLSI, 2009. [5] 许文,张芹,胡明,等.恶性肿瘤患者感染调查及相关因素分析[J].中华医院感染学杂志,2016,26(11):2526-2528. [6] 陈艳华,黄玲莎,陆一平,等.肿瘤患者感染产ESBLs大肠埃希氏菌的耐药性及危险因素分析[J].广西医科大学学报,2015,32(2):269-271. [7] Nordmann P. Trends in beta-lactam resistance among Enterobacteriaceae[J]. Clin Infect Dis, 1998, 27 Suppl 1: S100-106. [8] 冯雅君,沈萍,杜小幸,等.产碳青霉烯酶KPC-2肺炎克雷伯菌局部流行[J]. 浙江医学,2008,30(9):923-925,930. [9] Lee CR, Lee JH, Park KS, et al.Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and detection Methods[J]. Front Microbiol, 2016, 7: 895. [10] Vasoo S, Barreto JN, Tosh PK.Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician[J]. Mayo Clin Procs, 2015, 90(3): 395-403. [11] 林琳,王晶,肖晓光,等.重症病房耐碳青霉烯肺炎克雷伯菌KPC基因检测及同源性分析[J].国际检验医学杂志,2018,39(7):798-800,804. [12] 彭乃杰,林哈妮,夏菲,等.碳青霉烯类耐药肺炎克雷伯菌耐药机制和多位点序列分型研究[J].检验医学,2013,28(9):862-863. |